Finance

Lists
OSUR:NASDAQ
OraSure Technologies Inc
USD 3,62
0,00%
(0,00) 1D
13 Nov., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OSUR...
Open
USD 3,61
High
USD 3,68
Low
USD 3,54
Mkt. cap
249,95 m
Avg. vol.
615,61 k
Volume
409,01 k
52-wk high
USD 4,58
52-wk low
USD 2,08
EPS
-USD 0,69
Beta
1,08
Shares outstanding
69,05 m
No. of employees
500
Open
USD 3,61
High
USD 3,68
Low
USD 3,54
Mkt. cap
249,95 m
Avg. vol.
615,61 k
Volume
409,01 k
52-wk high
USD 4,58
52-wk low
USD 2,08
EPS
-USD 0,69
Beta
1,08
Shares outstanding
69,05 m
No. of employees
500
News stories
From web sources and news partners
Profile
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. Wikipedia
About OraSure Technologies Inc
CEOCarrie Eglinton Manner
Employees500
Founded11 Des. 1987
HeadquartersBethlehem, Pennsilvanië, Verenigde State van Amerika
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 1 analyst giving stock ratings to OSUR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for OSUR in the last 3 months
Highest
Current USD 3,62
USD 7,00 (+93,37%)
Average
USD 7,00 (+93,37%)
Lowest
USD 7,00 (+93,37%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Bonello
Craig-Hallum
Buy
Initiated
USD 7,00
+93,4%
10/23/2026
Last report
10 Nov. 2026
Fiscal period
Q3 2026
-USD 0,15 / -USD 0,18
+16,67%beat
Revenue / Est. (USD)
30,91 m / 31,02 m
-0,37%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
26,76 m
27,92 m
30,64 m
30,91 m
Cost of goods sold
15,80 m
16,06 m
17,32 m
16,94 m
Cost of revenue
15,80 m
16,06 m
17,32 m
16,94 m
Research and development expenses
11,42 m
13,39 m
9,44 m
7,63 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,90 m
20,39 m
21,03 m
18,55 m
Operating expense
27,32 m
33,78 m
30,47 m
26,18 m
Total operating expenses
43,12 m
49,83 m
47,79 m
43,12 m
Operating income
-16,35 m
-21,91 m
-17,15 m
-12,21 m
Other non operating income
1,87 m
128,00 k
272,00 k
83,00 k
EBT including unusual items
-19,08 m
-22,81 m
6,30 m
-12,39 m
EBT excluding unusual items
-15,32 m
-21,45 m
-16,29 m
-11,64 m
Income tax expense
210,00 k
-432,00 k
55,00 k
708,00 k
Effective tax rate
-1,10%
1,89%
0,87%
-5,72%
Other operating expenses
-
-
-
-
Net income
-19,29 m
-22,38 m
6,25 m
-13,09 m
Net profit margin
-72,06%
-80,13%
20,40%
-42,37%
Earnings per share
-0,19
-0,24
-0,20
-0,15
Interest and investment income
-
1,22 m
1,20 m
1,05 m
Interest expense
-
-
-
-
Net interest expenses
-
1,22 m
1,20 m
1,05 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,95 m
-19,57 m
-14,78 m
-10,01 m
Gain or loss from assets sale
268,00 k
-
-20,00 k
746,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google-programme